Login to Your Account



Financings Roundup

Start-up Epiomed Closes First Round for Anti-Emetic Work

By Jennifer Boggs


Tuesday, June 7, 2011
The work at Epiomed Therapeutics Inc. dates back to NASA's efforts back in the 1980s to reduce motion sickness on the space shuttle, but the semivirtual biotech start-up has tweaked those early discoveries and set its sights on the multi-billion-dollar nausea and vomiting market.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription